| Financial Year |
March 31 2023 |
| Monetary Funds |
2,316,913,842.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
268,478,517.19 |
| Accounts Receivable |
1,662,886,826.25 |
| Advances to Suppliers |
205,376,933.44 |
| Other Receivables |
83,209,311.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,522,192,010.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
433,426,254.53 |
| Total Current Assets |
7,666,074,256.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,239,530.22 |
| Investment Properties |
-- |
| Fixed Assetes |
2,708,081,306.36 |
| Under-construction Projects |
1,051,588,696.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
555,261,658.92 |
| R&D expenses |
-- |
| Goodwill |
450,491,499.54 |
| Long-Term Deferred and Prepaid Expenses |
6,031,679.90 |
| Deferred Income Tax Assets |
169,334,098.07 |
| Other Non-Current Assets |
205,261,827.01 |
| Sub-Total of Non-Current Assets |
5,370,884,556.36 |
| Total Assets |
13,036,958,812.98 |
| Short-Term Loans |
2,672,176,881.06 |
| Trading Financial liabilities |
-- |
| Notes Payable |
593,524,070.30 |
| Accounts Payable |
1,008,169,347.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
46,921,896.14 |
| Taxes Payable |
98,956,421.13 |
| Interest Payable |
1,161,388.89 |
| Dividend Payable |
-- |
| Other payables |
40,352,495.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
223,290,486.11 |
| Other Current Liabilities |
34,176,764.95 |
| Sub-Total of Current Liabilities |
4,773,717,630.72 |
| Long-term Loans |
1,430,092,407.66 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
9,360,840.37 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,601,310,298.70 |
| Total Liabilities |
6,375,027,929.42 |
| Paid-In Capital(Or Share Stock) |
581,666,921.00 |
| Capital Surplus |
3,883,985,473.93 |
| Surplus Reserve |
74,835,048.17 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,075,048,978.66 |
| Minority Stockholder's Interest |
1,007,256,355.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,654,674,528.30 |
| Owner's Equity（Stockholder's Equity） |
6,661,930,883.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
13,036,958,812.98 |
